| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
CureVac N.V (NASDAQ: CVAC)
CVAC Technical Analysis
5
| As on 9th Jun 2023 CVAC STOCK Price closed @ 9.71 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 15.70 & Strong Sell for SHORT-TERM with Stoploss of 23.94 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CVACSTOCK Price
| Open | 10.53 | Change | Price | % |
| High | 10.66 | 1 Day | -0.79 | -7.52 |
| Low | 9.67 | 1 Week | 0.56 | 6.12 |
| Close | 9.71 | 1 Month | 2.46 | 33.93 |
| Volume | 497559 | 1 Year | -31.34 | -76.35 |
| 52 Week High 41.05 | 52 Week Low 5.75 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CVAC Daily Charts |
CVAC Intraday Charts |
Whats New @ Bazaartrend |
CVAC Free Analysis |
|
|
CVAC Important Levels Intraday
| RESISTANCE | 11.62 |
| RESISTANCE | 11.01 |
| RESISTANCE | 10.63 |
| RESISTANCE | 10.25 |
| SUPPORT | 9.17 |
| SUPPORT | 8.79 |
| SUPPORT | 8.41 |
| SUPPORT | 7.80 |
CVAC Forecast May 2024
| 4th UP Forecast | 44.11 |
| 3rd UP Forecast | 33.08 |
| 2nd UP Forecast | 26.26 |
| 1st UP Forecast | 19.44 |
| 1st DOWN Forecast | -0.02 |
| 2nd DOWN Forecast | -6.84 |
| 3rd DOWN Forecast | -13.66 |
| 4th DOWN Forecast | -24.69 |
CVAC Weekly Forecast
| 4th UP Forecast | 20.83 |
| 3rd UP Forecast | 17.26 |
| 2nd UP Forecast | 15.06 |
| 1st UP Forecast | 12.85 |
| 1st DOWN Forecast | 6.57 |
| 2nd DOWN Forecast | 4.36 |
| 3rd DOWN Forecast | 2.16 |
| 4th DOWN Forecast | -1.41 |
CVAC Forecast2024
| 4th UP Forecast | 78.04 |
| 3rd UP Forecast | 56.13 |
| 2nd UP Forecast | 42.58 |
| 1st UP Forecast | 29.04 |
| 1st DOWN Forecast | -9.62 |
| 2nd DOWN Forecast | -23.16 |
| 3rd DOWN Forecast | -36.71 |
| 4th DOWN Forecast | -58.62 |
CureVac N.V ( NASDAQ USA Symbol : CVAC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CVAC Business Profile
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidate against COVID-19; CV7202, a prophylactic mRNA-based vaccine, which is in Phase 1 clinical trial for rabies virus glycoprotein; vaccine for lassa yellow fever; vaccine for respirational syncytial virus; CV7301, a second-generation lipid nanoparticle flu vaccine; and vaccines for rota, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CV9202 (BI 1361849), a self-adjuvanting mRNA vaccine that is in Phase 1 clinical trial for non-small cell lung cancer, as well as tumor associated antigens and shared neo-antigens. In addition, it is developing protein-based therapies for Cas9 gene-editing, ocular diseases, and lung respiratory diseases, as well as therapeutic antibodies. The company was founded in 2000 and is headquartered in Tübingen, Germany. Address: Friedrich-Miescher-Strasse 15, Tübingen, Germany, 72076
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service